Functional peptide KP24 enhances submandibular gland tissue growth in vitro

Atsushi Ikeda, Hiroaki Taketa, Gulsan Ara Sathi, Yoshiaki Hirano, Seiji Iida, Takuya Matsumoto

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction: Salivary gland hypofunction, also known as xerostomia, occurs as a result of radiotherapy for head and neck cancer, autoimmune diseases, or aging. Xerostomia leads to oral health problems and thus affects the quality of life. Biological salivary gland tissue generated in vitro would provide an alternative mode of treatment for this disease. Methods: To develop a novel method for modulating salivary gland tissue growth in vitro, we prepared a KP24 peptide-immobilized hydrogel sheet, wherein the peptide comprised repeating proline and lysine sequences, and evaluated the effect of this peptide on salivary gland tissue growth. Results: We found that the KP24 peptide has the potential to enhance glandular tissue growth in vitro. This enhancement is associated with neurite outgrowth and increasing neural innervation. Conclusion: KP24 peptide modified material would be a promising material for the modulation of salivary gland tissue growth in vitro.

Original languageEnglish
Pages (from-to)108-113
Number of pages6
JournalRegenerative Therapy
Volume3
DOIs
Publication statusPublished - Mar 1 2016

Fingerprint

Submandibular Gland
Salivary Glands
Peptides
Tissue
Growth
Xerostomia
Hydrogel
Oral Health
Radiotherapy
Head and Neck Neoplasms
Medical problems
Proline
Hydrogels
Autoimmune Diseases
Lysine
Aging of materials
Quality of Life
Modulation
In Vitro Techniques

Keywords

  • Functional peptide
  • Hydrogel
  • Submandibular gland
  • Tissue manipulation

ASJC Scopus subject areas

  • Biomedical Engineering
  • Developmental Biology
  • Biomaterials

Cite this

Functional peptide KP24 enhances submandibular gland tissue growth in vitro. / Ikeda, Atsushi; Taketa, Hiroaki; Sathi, Gulsan Ara; Hirano, Yoshiaki; Iida, Seiji; Matsumoto, Takuya.

In: Regenerative Therapy, Vol. 3, 01.03.2016, p. 108-113.

Research output: Contribution to journalArticle

@article{508c1f6ea00443f8aa34deae495d5454,
title = "Functional peptide KP24 enhances submandibular gland tissue growth in vitro",
abstract = "Introduction: Salivary gland hypofunction, also known as xerostomia, occurs as a result of radiotherapy for head and neck cancer, autoimmune diseases, or aging. Xerostomia leads to oral health problems and thus affects the quality of life. Biological salivary gland tissue generated in vitro would provide an alternative mode of treatment for this disease. Methods: To develop a novel method for modulating salivary gland tissue growth in vitro, we prepared a KP24 peptide-immobilized hydrogel sheet, wherein the peptide comprised repeating proline and lysine sequences, and evaluated the effect of this peptide on salivary gland tissue growth. Results: We found that the KP24 peptide has the potential to enhance glandular tissue growth in vitro. This enhancement is associated with neurite outgrowth and increasing neural innervation. Conclusion: KP24 peptide modified material would be a promising material for the modulation of salivary gland tissue growth in vitro.",
keywords = "Functional peptide, Hydrogel, Submandibular gland, Tissue manipulation",
author = "Atsushi Ikeda and Hiroaki Taketa and Sathi, {Gulsan Ara} and Yoshiaki Hirano and Seiji Iida and Takuya Matsumoto",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.reth.2016.02.006",
language = "English",
volume = "3",
pages = "108--113",
journal = "Regenerative Therapy",
issn = "2352-3204",
publisher = "Japanese Society of Regenerative Medicine",

}

TY - JOUR

T1 - Functional peptide KP24 enhances submandibular gland tissue growth in vitro

AU - Ikeda, Atsushi

AU - Taketa, Hiroaki

AU - Sathi, Gulsan Ara

AU - Hirano, Yoshiaki

AU - Iida, Seiji

AU - Matsumoto, Takuya

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Introduction: Salivary gland hypofunction, also known as xerostomia, occurs as a result of radiotherapy for head and neck cancer, autoimmune diseases, or aging. Xerostomia leads to oral health problems and thus affects the quality of life. Biological salivary gland tissue generated in vitro would provide an alternative mode of treatment for this disease. Methods: To develop a novel method for modulating salivary gland tissue growth in vitro, we prepared a KP24 peptide-immobilized hydrogel sheet, wherein the peptide comprised repeating proline and lysine sequences, and evaluated the effect of this peptide on salivary gland tissue growth. Results: We found that the KP24 peptide has the potential to enhance glandular tissue growth in vitro. This enhancement is associated with neurite outgrowth and increasing neural innervation. Conclusion: KP24 peptide modified material would be a promising material for the modulation of salivary gland tissue growth in vitro.

AB - Introduction: Salivary gland hypofunction, also known as xerostomia, occurs as a result of radiotherapy for head and neck cancer, autoimmune diseases, or aging. Xerostomia leads to oral health problems and thus affects the quality of life. Biological salivary gland tissue generated in vitro would provide an alternative mode of treatment for this disease. Methods: To develop a novel method for modulating salivary gland tissue growth in vitro, we prepared a KP24 peptide-immobilized hydrogel sheet, wherein the peptide comprised repeating proline and lysine sequences, and evaluated the effect of this peptide on salivary gland tissue growth. Results: We found that the KP24 peptide has the potential to enhance glandular tissue growth in vitro. This enhancement is associated with neurite outgrowth and increasing neural innervation. Conclusion: KP24 peptide modified material would be a promising material for the modulation of salivary gland tissue growth in vitro.

KW - Functional peptide

KW - Hydrogel

KW - Submandibular gland

KW - Tissue manipulation

UR - http://www.scopus.com/inward/record.url?scp=85041055337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041055337&partnerID=8YFLogxK

U2 - 10.1016/j.reth.2016.02.006

DO - 10.1016/j.reth.2016.02.006

M3 - Article

VL - 3

SP - 108

EP - 113

JO - Regenerative Therapy

JF - Regenerative Therapy

SN - 2352-3204

ER -